Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cameron

Showing results (1471-1480 of 1,773) with videos related to

Pageof 178
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European PanelP Hadji, R E Coleman, C Wilson, et al.
Nature|November 30, 2022
Structure-based design of bitopic ligands for the µ-opioid receptorAbdelfattah Faouzi, Haoqing Wang, Saheem A Zaidi, et al.
Journal of Medicinal Chemistry|November 21, 2022
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for GlioblastomaLakshmi R Bollu, Prashant V Bommi, Paige J Monsen, et al.
Frontiers in Cardiovascular Medicine|April 16, 2026
Co-produced evidence-based recommendations for cascade screening and secondary prevention in the relatives of people diagnosed with non-syndromic thoracic aortic diseaseR G Abbasciano, J C Dionne, J Miksza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2025
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02S A Hurvitz, S Loi, J O'Shaughnessy, et al.
Nature Cancer|April 15, 2022
An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancerCiric To, Tyler S Beyett, Jaebong Jang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Extending the clinical research network approach to all of healthcareJ Darbyshire, J Sitzia, D Cameron, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Development of Clinically Viable Non-Muscle Myosin II Small Molecule Inhibitors with Broad Therapeutic PotentialLaszlo Radnai, Erica J Young, Carlos Kikuti, et al.
BMC Geriatrics|February 4, 2018
Standard set of health outcome measures for older personsAsangaedem Akpan, Charlotte Roberts, Karen Bandeen-Roche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2008
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trialM Untch, R D Gelber, C Jackisch, et al.
Pageof 178

Showing results (1471-1480 of 1,773) with videos related to

Sort By:
Pageof 178
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European PanelP Hadji, R E Coleman, C Wilson, et al.
Nature|November 30, 2022
Structure-based design of bitopic ligands for the µ-opioid receptorAbdelfattah Faouzi, Haoqing Wang, Saheem A Zaidi, et al.
Journal of Medicinal Chemistry|November 21, 2022
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for GlioblastomaLakshmi R Bollu, Prashant V Bommi, Paige J Monsen, et al.
Frontiers in Cardiovascular Medicine|April 16, 2026
Co-produced evidence-based recommendations for cascade screening and secondary prevention in the relatives of people diagnosed with non-syndromic thoracic aortic diseaseR G Abbasciano, J C Dionne, J Miksza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2025
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02S A Hurvitz, S Loi, J O'Shaughnessy, et al.
Nature Cancer|April 15, 2022
An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancerCiric To, Tyler S Beyett, Jaebong Jang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Extending the clinical research network approach to all of healthcareJ Darbyshire, J Sitzia, D Cameron, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Development of Clinically Viable Non-Muscle Myosin II Small Molecule Inhibitors with Broad Therapeutic PotentialLaszlo Radnai, Erica J Young, Carlos Kikuti, et al.
BMC Geriatrics|February 4, 2018
Standard set of health outcome measures for older personsAsangaedem Akpan, Charlotte Roberts, Karen Bandeen-Roche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2008
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trialM Untch, R D Gelber, C Jackisch, et al.
Pageof 178